1. Home
  2. HTGC vs TARS Comparison

HTGC vs TARS Comparison

Compare HTGC & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hercules Capital Inc.

HTGC

Hercules Capital Inc.

HOLD

Current Price

$15.46

Market Cap

2.9B

Sector

Finance

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$62.96

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTGC
TARS
Founded
2003
2016
Country
United States
United States
Employees
50
N/A
Industry
Investment Managers
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.7B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
HTGC
TARS
Price
$15.46
$62.96
Analyst Decision
Buy
Buy
Analyst Count
7
6
Target Price
$18.86
$89.00
AVG Volume (30 Days)
1.4M
462.7K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
12.13%
N/A
EPS Growth
N/A
48.21
EPS
N/A
N/A
Revenue
N/A
$451,360,000.00
Revenue This Year
$11.18
$56.43
Revenue Next Year
$5.24
$30.19
P/E Ratio
$8.61
N/A
Revenue Growth
N/A
146.71
52 Week Low
$13.70
$38.51
52 Week High
$19.67
$85.25

Technical Indicators

Market Signals
Indicator
HTGC
TARS
Relative Strength Index (RSI) 48.11 54.47
Support Level $15.22 $61.24
Resistance Level $15.96 $66.36
Average True Range (ATR) 0.28 2.68
MACD 0.01 0.48
Stochastic Oscillator 54.35 81.96

Price Performance

Historical Comparison
HTGC
TARS

About HTGC Hercules Capital Inc.

Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: